Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  AGE

• Publication date

  2016-01-28

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s11357-016-9871-8PMID 26820749PMCID PMC5005871
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study

  2015influential reference
• Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients?

  2014cited by this paper
• Serum uric acid and risk of dementia in Parkinson's disease.

  2014influential reference
• The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses

  2014cited by this paper
• Association of serum uric acid level with muscle strength and cognitive function among Chinese aged 50–74 years

  2013cited by this paper
• Altered Levels of Homocysteine and Serum Natural Antioxidants Links Oxidative Damage to Alzheimer's Disease

  2013influential reference
• Ischemia Modified Albumin and Plasma Oxidative Stress Markers in Alzheimer's Disease

  2013influential reference
• Systemic oxidative stress in older patients with mild cognitive impairment or late onset Alzheimer's disease.

  2013influential reference
• The Relation of Uric Acid to Brain Atrophy and Cognition: The Rotterdam Scan Study

  2013cited by this paper
• Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes

  2013cited by this paper
• Serum uric acid levels and the clinical characteristics of depression.

  2012influential reference
• The relationship of serum uric acid level with depression and cognitive dysfunction in elderly patients with PD

  2012influential reference
• Serum Uric Acid in Patients with Parkinson’s Disease and Vascular Parkinsonism: A Cross-Sectional Study

  2012influential reference
• Serum and Cerebrospinal Fluid Uric Acid Levels in Lewy Body Disorders: Associations with Disease Occurrence and Amyloid-β Pathway

  2011influential reference
• Uric acid and cognition in Parkinson's disease: a follow-up study.

  2011influential reference
• Relationship between Uric Acid and Subtle Cognitive Dysfunction in Chronic Kidney Disease

  2011influential reference
• Relation of serum uric acid level with cognitive functions and number of plaques in patients with relapsing-remitting multiple sclerosis/Relapsing-remitting multipl skleroz hastalarinda serum urik asit duzeyinin kognitif fonksiyonlar ve plak sayisi ile iliskisi

  2010cited by this paper
• Uric Acid as a CNS Antioxidant

  2010influential reference
• Vitamin E and Enzymatic/Oxidative Stress-Driven Oxysterols in Amnestic Mild Cognitive Impairment Subtypes and Alzheimer's Disease

  2010influential reference
• Association of cognitive function with serum uric acid level among Chinese nonagenarians and centenarians.

  2010influential reference
• Urate as a predictor of the rate of clinical decline in Parkinson disease.

  2009cited by this paper
• Uric Acid and Dementia in Community-Dwelling Older Persons

  2009cited by this paper
• [Study on uric acid and the related factors associated with cognition in the patients with Parkinson's disease].

  2009influential reference
• Serum homocysteine: interplay with other circulating and genetic factors in association to Alzheimer's type dementia.

  2009influential reference
• Relationship between the level of serum uric acid and Alzheimer's disease.

  2009influential reference
• Serum uric acid and cognitive function and dementia.

  2008influential reference
• Uric acid associates with cognition in Parkinson's disease.

  2008influential reference
• Cerebral Ischemia Mediates the Effect of Serum Uric Acid on Cognitive Function

  2008influential reference
• Peripheral Oxidative Damage in Mild Cognitive Impairment and Mild Alzheimer's Disease

  2008influential reference
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  2008cited by this paper
• Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia.

  2008influential reference
• Plasma Urate and Progression of Mild Cognitive Impairment

  2008influential reference
• Chapter 8: Assessing risk of bias in included studies

  2008cited by this paper
• Serum uric acid and brain ischemia in normal elderly adults

  2007cited by this paper
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies

  2007cited by this paper
• Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

  2007cited by this paper
• Decreased plasma antioxidants in patients with Alzheimer's disease

  2006influential reference
• Oxidative stress in Alzheimer patients in different stages of the disease.

  2006influential reference
• Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?

  2006cited by this paper
• Cognitive impairment in chronic kidney disease.

  2006cited by this paper
• Study of plasma antioxidant status in Alzheimer's disease

  2005cited by this paper
• Consensus Statement

  2004cited by this paper
• Cognitive Impairment in Chronic Kidney Disease

  2004influential reference
• Purine-rich foods, dairy and protein intake, and the risk of gout in men.

  2004cited by this paper
• Plasma Antioxidant Status, Immunoglobulin G Oxidation and Lipid Peroxidation in Demented Patients: Relevance to Alzheimer Disease and Vascular Dementia

  2004influential reference
• Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.

  2003influential reference
• Cardiovascular Drugs and Serum Uric Acid

  2003cited by this paper
• Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease

  2002cited by this paper
• Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

  2000cited by this paper
• Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease.

  1999influential reference
• Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo

  1998cited by this paper
• No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease

  1995influential reference
• The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease

  1993influential reference
• Hypouricemia, Abnormal Renal Tubular Urate Transport, and Plasma Natriuretic Factor(s) in Patients with Alzheimer's Disease

  1993influential reference
• Routine blood chemistry screen: a diagnostic aid for Alzheimer's disease.

  1989influential reference
• [Hematocrit, serum lipids and cardiovascular indices as risk factors in vascular dementia].

  1988influential reference
• Cerebrospinal fluid investigations in multi‐infarct dementia and senile dementia

  1981cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Proteomic footprint of serum urate concentration and urate transporter ABCG2 dysfunctional polymorphism: a cross-sectional study

  2026cites this paper
• Effect of serum uric acid to creatinine ratio on cognitive function decline in middle-aged adults: Longitudinal evidence from CHARLS

  2025cites this paper
• Hyperuricemia reduces the risk of MCI but not dementia: a cross-sectional study in Liuyang

  2025cites this paper
• Cognitive impairment and blood biomarkers of renal dysfunction in high-risk Nigerian population, with special attention to women and diabetes

  2025cites this paper
• Interpretable machine learning for cognitive impairment prediction in Parkinson’s disease: a multicenter validation study with SHAP analysis

  2025cites this paper
• Progression of cognitive impairment in Parkinson’s disease correlates with uric acid concentration

  2024cites this paper
• Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective

  2024cites this paper
• Correlation and influencing factors of neurophysiological examinations and serum uric acid in patients with diabetic peripheral neuropathy: an exploratory study

  2024cites this paper
• Potential biofluid markers for cognitive impairment in Parkinson’s disease

  2024cites this paper
• Changes in serum uric acid, glutathione, and amyloid-β1-42 levels in Parkinson’s disease patients and their association with disease progression and cognitive decline

  2024cites this paper
• Gout or Hyperuricemia and Dementia Risk: A Meta-Analysis of Observational Studies

  2024cites this paper
• Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial

  2023cites this paper
• Role of uric acid as a biomarker of cognitive function in schizophrenia during maintenance period

  2023cites this paper
• Could Alzheimer's disease be a maladaptation of an evolutionary survival pathway mediated by intracerebral fructose and uric acid metabolism?

  2023cites this paper
• Kewaspadaan Penyakit Dementia Melalui Edukasi Gaya Hidup Dan Skrining Albuminuria, Low-Density Lipoprotein (Ldl), Serta Asam Urat

  2023cites this paper
• Insiden mild cognitive impairment tipe amnestik dan non-amnestik pada kelompok usia lanjut di Puskesmas Uabau

  2023cites this paper
• Glutathione-Mediated Neuroprotective Effect of Purine Derivatives

  2023cites this paper
• Uric acid and neurological disease: a narrative review

  2023cites this paper
• Association of serum uric acid and fasting plasma glucose with cognitive function: a cross-sectional study

  2023cites this paper
• The association between serum uric acid and cognitive performance in patients with ischemic stroke is modified by estimated glomerular filtration rate

  2023cites this paper
• Dysuricemia—A New Concept Encompassing Hyperuricemia and Hypouricemia

  2023cites this paper
• Hyperuricemia may be associated with muscle wellness in older adults

  2023cites this paper
• Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean

  2023cites this paper
• Temporal trends in the prevalence and characteristics of hypouricaemia: a descriptive study of medical check-up and administrative claims data

  2022cites this paper
• Hyperuricémies non goutteuses

  2022cites this paper
• Cognitive Dysfunction and Its Risk Factors in Patients Undergoing Maintenance Hemodialysis

  2022cites this paper
• Cognitive Dysfunction and Its Risk Factors in Patients Undergoing Maintenance Hemodialysis

  2022cites this paper
• Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study

  2022cites this paper
• Allopurinol use and the risk of dementia: A meta-analysis of case–control studies

  2022cites this paper
• The relationship between uric acid and brain health from observational studies

  2022cites this paper
• Serum uric acid and diabetic peripheral neuropathy: a double-edged sword

  2022cites this paper
• Cognitive Status and Nutritional Markers in a Sample of Institutionalized Elderly People

  2022cites this paper
• Impact of Clinical Association Between Gout and Dementia: A Nationwide Population‐Based Cohort Study in Korea

  2022cites this paper
• Uric Acid and Cognitive Impairment in Patients with Acute Ischemic Stroke: A Meta-Analysis.

  2022cites this paper
• Risk of Parkinson's disease in a gout Mediterranean population: A case-control study.

  2022cites this paper
• The Influence of Serum Uric Acid on the Brain and Cognitive Dysfunction

  2022cites this paper
• Hypouricemia and Urate Transporters

  2022cites this paper
• Incident Gout: Risk of Death and Cause-Specific Mortality in Western Sweden: A Prospective, Controlled Inception Cohort Study

  2022cites this paper
• Association between urate-lowering therapies and cognitive decline in community-dwelling older adults

  2022cites this paper
• The Influence of Serum Uric Acid Level on Alzheimer's Disease: A Narrative Review

  2021cites this paper
• Serum Uric Acid and the Risk of Dementia: A Systematic Review and Meta-Analysis

  2021cites this paper
• Association between Anti-inflammatory Drug and Dementia in Patients with Gout: A Nationwide, Population-Based Nested Case-Control Study

  2021cites this paper
• Uric Acid Associates With Executive Function in Children and Adolescents With Hypertension

  2021cites this paper
• Serum Uric Acid May Aggravate Alzheimer’s Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study

  2021cites this paper
• Asymptomatic hyperuricemia: secret relationships, invisible effects and potential complications

  2021cites this paper
• Cognitive Impairment in Parkinson’s Disease: Epidemiology, Clinical Profile, Protective and Risk Factors

  2021influential citation
• Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia

  2021cites this paper
• High Blood Uric Acid Is Associated With Reduced Risks of Mild Cognitive Impairment Among Older Adults in China: A 9-Year Prospective Cohort Study

  2021cites this paper
• Markers of Kidney Function and Longitudinal Cognitive Ability Among Older Community-Dwelling Adults: The Rancho Bernardo Study

  2021cites this paper
• Biomarkers of kidney function and cognitive ability: A Mendelian randomization study.

  2021cites this paper
• ASYMPTOMATIC HYPERURICEMIA: SECRET RELATIONSHIPS, INVISIBLE EFFECTS AND POTENTIAL COMPLICATIONS

  2021cites this paper
• Hyperuricemia, Gout, and the Brain—an Update

  2021cites this paper
• Association Between Urate-Lowering Therapies and Cognitive Decline in Community-Dwelling Older Adults: A Post-Hoc Analysis of the MAPT Study.

  2021cites this paper
• 尿酸・（酸性尿）と諸疾患との関連性:―最近の話題―

  2020cites this paper
• Asymptomatic hyperuricemia: is it really asymptomatic?

  2020cites this paper
• Serum Uric Acid and High-Sensitivity C-Reactive Protein as Predictors of Cognitive Impairment in Patients with Cerebral Infarction

  2020cites this paper
• Positive Association of Ascorbate and Inverse Association of Urate with Cognitive Function in People with Parkinson’s Disease

  2020cites this paper
• Cerebral Fructose Metabolism as a Potential Mechanism Driving Alzheimer’s Disease

  2020cites this paper
• On the Clinical Pharmacology of Reactive Oxygen Species

  2020cites this paper
• The relationship between serum uric acid and cognitive function in patients with chronic heart failure

  2020cites this paper
• The biology of urate.

  2020cites this paper
• 2020 American College of Rheumatology Guideline for the Management of Gout

  2020cites this paper
• Comparative Study of Real‐Life Management Strategies in Gout: Data From Two Protocolized Gout Clinics

  2020cites this paper
• Plasma parameters and risk factors of patients with post-stroke cognitive impairment.

  2020cites this paper
• Uric acid is associated with cognitive impairment in the elderly patients receiving maintenance hemodialysis—A two‐center study

  2020cites this paper
• Management of hyperuricemia in asymptomatic patients: A critical appraisal.

  2020cites this paper
• Pro-Aging Effects of Xanthine Oxidoreductase Products

  2020cites this paper
• Relationship Between Metabolic Syndrome and Serum Uric Acid in an Iranian Community Elderly Population: A Cohort Aging Study

  2019cites this paper
• The Cognitive Effect of Uric Acid in Idiopathic Parkinson’s Patients

  2019cites this paper
• Uric Acid and High-Density Lipoprotein Cholesterol Are Differently Associated with Alzheimer’s Disease and Vascular Dementia

  2019cites this paper
• Debates in gout management.

  2019cites this paper
• Agricultural work and reduced circulating uric acid are both associated with initial hospital admission for Parkinson’s disease

  2019cites this paper
• Hypouricemia: what the practicing rheumatologist should know about this condition

  2019cites this paper
• Influences of the Global Deterioration Scale according to Routine Blood Chemistry Results

  2019cites this paper
• Genetically Determined Uric Acid and the Risk of Cardiovascular and Neurovascular Diseases: A Mendelian Randomization Study of Outcomes Investigated in Randomized Trials

  2019cites this paper
• Uric Acid Has Different Effects on Spontaneous Brain Activities of Males and Females: A Cross-Sectional Resting-State Functional MR Imaging Study

  2019cites this paper
• Cause‐Specific Mortality in Gout: Novel Findings of Elevated Risk of Non–Cardiovascular‐Related Deaths

  2019cites this paper
• U-Shaped Association Between Serum Uric Acid Levels and Cognitive Functions in Patients with Type 2 Diabetes: A Cross-Sectional Study

  2019cites this paper
• Effect of serum uric acid on cognition in patients with idiopathic REM sleep behavior disorder

  2018cites this paper
• Hyperuricemia and dementia – a case-control study

  2018cites this paper
• Uric Acid and Cognitive Function in Older Individuals

  2018influential citation
• Edinburgh Research Explorer MR-PheWAS

  2018cites this paper
• MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank

  2018cites this paper
• Circulating antioxidants and Alzheimer disease prevention: a Mendelian randomization study

  2018cites this paper
• Cognitive impairment in Parkinson’s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health

  2018cites this paper
• Long-Term Subclinical Hyperglycemia and Hypoglycemia as Independent Risk Factors for Mild Cognitive Impairment in Elderly People.

  2017cites this paper
• Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases

  2017cites this paper
• A Prospective Study on the Association between Uric Acid and Cognitive Function among Middle-Aged and Older Chinese

  2017cites this paper
• Serum uric acid and impaired cognitive function in community-dwelling elderly in Beijing.

  2017cites this paper
• Uric acid and incident dementia over 12 years of follow-up: a population-based cohort study

  2017cites this paper
• Response to: ‘Uric acid and incident dementia: a population-based cohort study’ by Lee and Song

  2017cites this paper
• Hyperuricemia as a Protective Factor for Mild Cognitive Impairment in Non-Obese Elderly.

  2017cites this paper
• Role of serum urate in neurocognitive function and dementia: new evidence contradicts old thinking

  2017cites this paper
• Sex-Dependent Associations of Serum Uric Acid with Brain Function During Aging

  2017cites this paper
• Serum uric acid is associated with better executive function in men but not in women: Baseline assessment of the ELSA‐Brasil study

  2017cites this paper
• Uric acid and cognitive decline: a double-edge sword?

  2017cites this paper
• Uric acid may be protective against cognitive impairment in older adults, but only in those without cardiovascular risk factors

  2017influential citation
• Lower serum uric acid is associated with mild cognitive impairment in early Parkinson’s disease: a 4-year follow-up study

  2016cites this paper